Position in SANA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,296,539
+$117,083 QoQ
Shares Held
1,231,100
-15.2% QoQ
Ownership
0.411%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#22
of 211 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. SANA ranks #91 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in SANA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,296,539 | 1,231,100 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,179,456 | 1,451,200 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,882,842 | 1,691,116 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,073,375 | 1,992,500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $556,133 | 203,712 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $521,303 | 319,818 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $68,640 | 16,500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $272,454 | 49,900 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,729,000 | 172,900 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,204,008 | 295,100 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $754,143 | 194,869 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $199,797 | 61,100 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $654,515 | 165,700 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,908,000 | 818,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,059,124 | 786,800 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,944,182 | 840,700 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $887,004 | 57,300 | Shares | Sole | 2022-02-11 | |
| 2021-06-30 | $436,452 | 22,200 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||